Adaptive Biotechnologies’ new HQ: Co-founders show off 100K square-foot space in Seattle After doubling its workforce during the pandemic, Adaptive Biotechnologies finally has room to grow. The company on Tuesday will cut… Read More
Tech Moves: Adaptive Biotech co-founders join life sciences SPAC; new edtech execs; and more — Adaptive Biotechnologies co-founders and brothers Chad and Harlan Robins are among the directors of a new life sciences SPAC.… Read More
Industry slowdown hits Adaptive Biotech’s bottom line as COVID immune initiatives show progress Adaptive Biotechnologies’ revenue fell 5% to $21 million in the second quarter, and its net loss more than doubled to… Read More
Adaptive Biotechnologies beats estimates with Q3 revenue of $26.1M as shares rise 6% Adaptive Biotechnologies‘ stock rose 6 percent to $30 per share in after-hours trading on Tuesday after the company reported higher… Read More
Adaptive Biotechnologies will triple size of its Seattle HQ following IPO Adaptive Biotechnologies is charting a massive expansion of its Seattle headquarters following the completion of a recent initial public offering.… Read More
Big debut: Shares of Adaptive Biotechnologies rise 100% on first day as public company Adaptive Biotechnologies had a heck of a first day as a public company. Shares of the Seattle-based biotech, which makes… Read More
Adaptive Biotechnologies stock soars 90% after ringing Nasdaq opening bell following $300M IPO Follow-up: Big debut: Shares of Adaptive Biotechnologies rise 100% on first day as public company The public market is bullish… Read More
Adaptive Biotechnologies set to go public with valuation above $2B in biggest biotech IPO of 2019 Adaptive Biotechnologies has raised the price for its initial public offering, putting itself in a position to raise more cash… Read More
Adaptive Biotechnologies co-founder leaves Fred Hutch; IPO filing warned of IP risks from dual roles Dr. Harlan Robins, co-founder and chief scientific officer of Seattle-based Adaptive Biotechnologies, stepped down from his role as head of… Read More
Tech Moves: Ex-Juno CEO Hans Bishop takes over at Grail; Amazon Business chief departs; Shyft co-founder jumps to Ally; and more — The former head of Juno Therapeutics, Hans Bishop, signed on as CEO of Grail, a Bay Area biotech focused… Read More
